Follow this exact reviewed peptide identity across selected source lanes.
Official matched intervention · Drug
thymosin alpha 1 clinical trials
3 selected ClinicalTrials.gov records carrying the official matched intervention thymosin alpha 1 (Drug). PeptideScanner includes the name only where it resolves exactly to the record’s reviewed peptide identity; it does not infer equivalence or treatment effect.
3 selected records.
1 profiles.
ClinicalTrials.gov intervention field.
Cross-source journeys
Explore connected peptide records
Across these connected profiles, PeptideScanner carries 30 selected PubMed records and 0 selected Drugs@FDA applications. That profile context is not a claim that those records concern this intervention or establish treatment effect.
Collection change ledger
Recently changed records on this intervention hub
These events come only from the exact registry records shown on this page. A matched intervention name does not establish equivalence, safety, effectiveness, or treatment effect.
ClinicalTrials.gov record NCT02646189
PeptideScanner retained ClinicalTrials.gov record NCT02646189 at 2026-11-15T22:10:40.222Z. Its registry update date was 2016-01-05, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- January 5, 2016
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT02883595
PeptideScanner retained ClinicalTrials.gov record NCT02883595 at 2026-11-15T22:10:40.222Z. Its registry update date was 2019-04-04, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- April 4, 2019
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT03659578
PeptideScanner retained ClinicalTrials.gov record NCT03659578 at 2026-11-15T22:10:40.222Z. Its registry update date was 2022-01-03, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- January 3, 2022
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Thymosin alpha-1 · 2022-01-03
ClinicalTrials.gov record NCT03659578
Completed at the retained observation.
Open attributed record →Thymosin alpha-1 · 2019-04-04
ClinicalTrials.gov record NCT02883595
Completed at the retained observation.
Open attributed record →Thymosin alpha-1 · 2016-01-05
ClinicalTrials.gov record NCT02646189
Completed at the retained observation.
Open attributed record →